« Back to Record
Citation APA

Jensen, D. M., Ouzan, D., Wright, M., Morano, L. E., Buynak, R., Bourlière, M., Hassanein, T., Nishiguchi, S., Kao, J. H., Omata, M., Paik, S., Asselah, T., Wong, D., Tam, E., Kaita, K., Victor Feinman, S., Stern, J. J., Scherer, J., Quinson, A. M., Voss, F., Gallivan, J. P., Böcher, W. O., Dieterich, D., Ferenci, P., Foster, G. R., Sulkowski, M., Zeuzem, S., Mantry, P., Yoshida, E. E., & Moreno, C. (2016). Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: Pooled analysis of two phase 3 trials. Annals of Hepatology, 15(3), 333-349. doi:10.5604/16652681.1198803


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231464

Jensen, D. M., Ouzan, D., Wright, M., Morano, L. E., Buynak, R., Bourlière, M., Hassanein, T., Nishiguchi, S., Kao, J. H., Omata, M., Paik, S., Asselah, T., Wong, D., Tam, E., Kaita, K., Victor Feinman, S., Stern, J. J., Scherer, J., Quinson, A. M., Voss, F., Gallivan, J. P., Böcher, W. O., Dieterich, D., Ferenci, P., Foster, G. R., Sulkowski, M., Zeuzem, S., Mantry, P., Yoshida, E. E., & Moreno, C. (2016). Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: Pooled analysis of two phase 3 trials. Annals of Hepatology, 15(3), 333-349. doi:10.5604/16652681.1198803